Depression Cure: What Works? - Dr. Dave Rabin
21 Jul 2024 · 1 min

0:55
In this segment, the speaker critiques the current standard of care for depression and PTSD, which relies heavily on selective serotonin reuptake inhibitors (SSRIs) such as Paxil and Zoloft. While acknowledging that SSRIs can provide short‑term stabilization, the speaker emphasizes their poor long‑term outcomes: over 70% of PTSD patients never achieve lasting remission, and even when SSRIs appear effective, about 80% of patients relapse after discontinuation, leading to a lifelong diagnosis. The discussion then introduces MDMA as a potential alternative therapeutic approach, suggesting that it may address the shortcomings of SSRIs, though the excerpt does not detail its efficacy.










